PROK – prokidney corp. - class a ordinary shares (US:NASDAQ)

News

ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
ProKidney (PROK) was downgraded by Wall Street Zen from "hold" to "se
ProKidney (PROK) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
ProKidney GAAP EPS of -$0.52 beats by $0.18, revenue of $0.89M beats by $0.35M [Seeking Alpha]
ProKidney Reports Full Year 2025 Financial Results and Business Highlights
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com